Teva indeed did buy up Cephalon already- but I like the quote they snuck in..
”The pipeline will ensure future growth as Copaxone faces competition and Cephalon’s top-selling drug, the narcolepsy treatment Provigil, loses patent protection next April, Teva Chief Executive Officer Shlomo Yanai said.”
“The company reported 2010 revenue of $2.81 billion, of which $1.12 billion came from Provigil.”
me gusta- just have the biggest generic drug maker scoop up one of the up and coming drug company who is about to bust because of their main money maker becoming generic soon…
